T60A
Showing 1 - 25 of >10,000
Malignant Solid Tumors Trial (T60c injection)
Not yet recruiting
- Malignant Solid Tumors
- T60c injection
- (no location specified)
Oct 7, 2023
Patisiran in Polyneuropathy of ATTRv Amyloidosis WithV122I or
Active, not recruiting
- Hereditary Transthyretin-mediated (ATTRv) Amyloidosis
- Polyneuropathy
-
Los Angeles, California
- +26 more
Mar 4, 2022
Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)
Recruiting
- Colorectal Cancer
- +6 more
- CEA-targeted CAR-T cells
-
Hangzhou, Zhejiang, China
- +1 more
Sep 18, 2023
A Real-World Evidence Long-Term Follow-Up Study to Assess
Not yet recruiting
- Aphakia
- AcrySof single-piece IOL
- AcrySof multi-piece IOL
- (no location specified)
Mar 23, 2023
B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +7 more
- Acalabrutinib
- Axicabtagene Ciloleucel
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 9, 2022
Influenza Trial in New Port Richey, Charlottesville (CAIV-T or TIV)
Completed
- Influenza
- CAIV-T or TIV
-
New Port Richey, Florida
- +1 more
Sep 10, 2021
Idiopathic Pulmonary Fibrosis Trial in Canada (60% Oxygen, Standard of Care)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 60% Oxygen
- Standard of Care
-
Calgary, Alberta, Canada
- +7 more
May 17, 2022
AML Trial in Moscow (allo-HSCT)
Recruiting
- AML
- allo-HSCT
-
Moscow, Russian FederationNational Research Center for Hematology
Apr 14, 2022
Premature Infant, Respiratory Distress Syndrome Trial in Edmonton (30% group, 60% group)
Completed
- Premature Infant
- Respiratory Distress Syndrome
- 30% group
- 60% group
-
Edmonton, Alberta, CanadaRoyal Alexandra Hospital
Sep 3, 2021
Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)
Not yet recruiting
- Aphakia
- Clareon Vivity/Vivity Toric Extended Vision IOL
- Clareon/Clareon Toric Aspheric IOL
-
Torrance, California
- +6 more
May 2, 2023
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma Trial in Duarte (Best Practice, Cognitive Intervention, Comprehensive Geriatric
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- Multiple Myeloma
- Best Practice
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 19, 2023
Clareon IOL Retrospective Data Collection
Not yet recruiting
- Aphakia
- Astigmatism
- Clareon UVA IOL
- +2 more
-
Fort Worth, TexasAlcon Research, LLC
Mar 22, 2023
Allergy Trial in Worldwide (5-grass mix SLIT-drops, Placebo)
Active, not recruiting
- Allergy
- 5-grass mix SLIT-drops
- Placebo
-
Brno, Czechia
- +47 more
Aug 12, 2022
Scleroderma, Systemic Trial in Worldwide (BI 685509, Placebo)
Recruiting
- Scleroderma, Systemic
- BI 685509
- Placebo
-
Liverpool, New South Wales, Australia
- +25 more
Jan 27, 2023
NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)
Completed
- Carcinoma, Non-Small-Cell Lung
- Neoplasms
- Debio 1143
- Avelumab
-
Edmonton, Alberta, Canada
- +8 more
May 30, 2022
Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor, Ovarian Cancer Trial in Canada, Poland, United States
Recruiting
- Ovarian Granulosa-Stromal Tumor
- +2 more
-
Los Angeles, California
- +20 more
Jul 13, 2022
NSCLC, Melanoma Trial (IMM60, Pembrolizumab)
Not yet recruiting
- Non-small Cell Lung Cancer
- Melanoma
- (no location specified)
Jan 24, 2023
Essential Tremor Trial in Canada, United States (100 mg PRAX-944, 60 mg PRAX-944, Placebo)
Active, not recruiting
- Essential Tremor
- 100 mg PRAX-944
- +3 more
-
Birmingham, Alabama
- +38 more
Jan 23, 2023
Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency Trial in Worldwide (Alpha-1 MP)
Enrolling by invitation
- Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
- Alpha-1 MP
-
Phoenix, Arizona
- +24 more
Dec 7, 2022
Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)
Recruiting
- Endometrial Cancer
- Atezolizumab - 28 Day Cycle
- +6 more
-
Duarte, California
- +13 more
Jun 8, 2022
Knee Osteoarthritis Trial in Roma (HYALUBRIX 60)
Recruiting
- Knee Osteoarthritis
- HYALUBRIX 60
-
Roma, ItalyUOC Medicina Fisica e Riabilitativa SMC09, AOU Policlinico Umber
Oct 30, 2023
Renal Anemia Trial in Beijing (JT1801 60ug, NESP 60ug)
Recruiting
- Renal Anemia
- JT1801 60ug
- NESP 60ug
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 17, 2023